The cannabis licensing authority CLA says it is not aware of any ganja deficiency affecting the locally regulated medical cannabis industry.
This follows media reports of a ganja deficiency on the island.
The agency routinely monitors licensees’ ganja inventory through the Enforcement and Monitoring Department, and there is no evidence of a shortage of ganja within the regulated area, according to Faith Graham, acting Senior Director of Operations.
She added that there was no such report from CLA licensees and that reviews with licensees confirmed that there was no shortcoming.
The agency assures the public that there is currently no cause for concern as it concerns the availability of cannabis to patients for medical, scientific and therapeutic purposes.